| 4NRA: reference: Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain., Ferguson FM, Fedorov O, Chaikuad A, Philpott M, Muniz JR, Felletar I, von Delft F, Heightman T, Knapp S, Abell C, Ciulli A, J Med Chem. 2013 Dec 27;56(24):10183-7. doi: 10.1021/jm401582c. Epub 2013 Dec 13. PMID: 24304323 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).